Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.3 USD | +7.29% | +13.01% | -17.32% |
May. 21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
May. 21 | Exscientia to Reduce Up to 25% Workforce by Year End | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,758 | 541.5 | 629.2 | 526.4 | - | - |
Enterprise Value (EV) 1 | 1,201 | 49.27 | 388.3 | 317.9 | 123 | -27.82 |
P/E ratio | -14.8 x | -4.54 x | -3.36 x | -4.95 x | -5.09 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 64.3 x | 19.9 x | 24.6 x | 9.1 x | 10.7 x | 15 x |
EV / Revenue | 43.9 x | 1.81 x | 15.2 x | 5.5 x | 2.51 x | -0.79 x |
EV / EBITDA | -23.7 x | -0.36 x | -2.42 x | -3.32 x | -1.04 x | 0.23 x |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | 3.12 x | 1.13 x | 1.76 x | 2.47 x | 3.97 x | - |
Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 | 126,375 | - | - |
Reference price 2 | 14.61 | 4.407 | 5.036 | 4.165 | 4.165 | 4.165 |
Announcement Date | 3/23/22 | 3/23/23 | 3/21/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 27.36 | 27.22 | 25.6 | 57.84 | 49.08 | 35 |
EBITDA 1 | -50.71 | -135.8 | -160.4 | -95.82 | -118.8 | -119.3 |
EBIT 1 | -54.9 | -145.3 | -224.3 | -106.3 | -125.3 | -122.2 |
Operating Margin | -200.65% | -533.71% | -876.17% | -183.79% | -255.37% | -349.15% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income 1 | -49.23 | -118.7 | -52.4 | -116.1 | -120 | - |
Net margin | -179.94% | -436.13% | -204.69% | -200.73% | -244.44% | - |
EPS 2 | -0.9900 | -0.9700 | -1.500 | -0.8410 | -0.8180 | - |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - |
Announcement Date | 3/23/22 | 3/23/23 | 3/21/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 17.6 | 4.14 | 6.975 | 7.223 | 6.298 | 6.813 | 7.1 | 3.8 | 8.882 | 3.1 | 5.29 | 20 | 45 | 29.71 |
EBITDA | -3.91 | -20.96 | - | - | - | - | - | -42.85 | -32.84 | -42.26 | - | - | - | - |
EBIT 1 | -5.3 | -22.88 | -24.7 | -34.2 | -41.32 | -51.31 | -56.5 | -59.1 | -37.22 | -59.4 | -27.01 | -25.06 | -6.565 | -28.22 |
Operating Margin | -30.11% | -552.75% | -354.12% | -473.56% | -656% | -753.13% | -795.77% | -1,555.26% | -419.06% | -1,916.13% | -510.6% | -125.32% | -14.59% | -94.99% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | -5.1 | -20.08 | - | - | - | - | - | -45.7 | -31.21 | -52.4 | - | - | - | - |
Net margin | -28.98% | -485.12% | - | - | - | - | - | -1,202.63% | -351.43% | -1,690.32% | - | - | - | - |
EPS | -0.0600 | -0.6700 | - | - | - | - | - | -0.3700 | -0.2500 | -0.4200 | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/17/21 | 3/23/22 | 5/25/22 | 8/17/22 | 11/15/22 | 3/23/23 | 5/24/23 | 8/10/23 | 11/9/23 | 3/21/24 | 5/21/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 557 | 492 | 241 | 209 | 403 | 554 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | -15.7% | -22.7% | -35% | -28.8% | -80.7% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | 4.680 | 3.880 | 2.860 | 1.690 | 1.050 | - |
Cash Flow per Share 2 | -0.1300 | -0.5000 | -0.9500 | -0.7500 | -0.8100 | - |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/23/22 | 3/23/23 | 3/21/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.32% | 670M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- EXAI Stock
- Financials Exscientia plc